2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$69.12+$0.05 (+0.08%)
Price as of Jun 23, 2026 7:57 PM EDT- $26.7BMarket Cap
- -13.49%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$69.12+$0.05 (+0.08%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $69.07 | ||
Change | -$3.40 (-4.69%) | ||
Open | $71.89 | ||
High | $71.92 | ||
Low | $68.55 | ||
Previous Close | $72.47 | ||
Volume | 5,570,883 | ||
30-Day Average Volume | 5,677,035 | ||
1-Week Change | -6.94% | ||
1-Month Change | -4.20% | ||
1-Year Change | -13.49% | ||
3-Year Change | -45.41% | ||
5-Year Change | -35.37% | ||
Fundamentals | |||
Shares Outstanding | 385.9M | ||
Total Assets | $6.6B | ||
Market Cap | $26.7B | ||
Enterprise Value | $26.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.2B | ||
Net Income | $199.5M | ||
Free Cash Flow | $449.0M | ||
EBIT | $271.6M | ||
EBITDA | $338.7M | ||
Net Working Capital | $2.1B | ||
EPS | $0.51 | ||
Enterprise Value/EBITDA | 79 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 9 | ||
P/E | 135 | ||
PEG | -6 | ||
Price/Free Cash Flow | 59 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue